RongCan Biotech’s mRNA HPV Vaccine Receives FDA Clinical Approval
China-based mRNA specialist RongCan (Shanghai) Biotech Co., Ltd announced that it has received clinical approval...
RongCan Biotech
NK Celltech and RongCan Biotech Partner to Advance mRNA NK Cell Therapy and LNP Delivery System
Shanghai-based NK Celltech and RongCan Biotech have entered into a partnership agreement to establish a...
RongCan Biotech Raises Pre-Series A Funding for mRNA Therapeutics Development
China-based nucleic acid-based therapeutics developer RongCan (Shanghai) Biotech Co., Ltd has reportedly raised “tens of...